Mclean Hospital

Gender/Sex Differences Related Content


Elena H. Chartoff, PhD

Elena H. Chartoff, PhD, is an assistant professor of psychiatry at Harvard Medical School and director of the Neurobiology of Motivated Behavior Laboratory at McLean Hospital. She is interested in the neurobiological mechanisms that connect depression and anxiety with drug addiction. The work in her laboratory has broad implications for understanding basic brain mechanisms that control mood and...

Shelly F. Greenfield, MD, MPH

Shelly F. Greenfield, MD, MPH, is an addiction psychiatrist, clinician, and researcher. She serves as principal and co-investigator on federally funded research focusing on substance use disorders treatment, gender differences, and substance health services. She received a National Institute on Drug Abuse (NIDA)-funded career award in substance use disorder patient oriented research and NIDA-...

Maria Mavrikaki, PhD

Maria Mavrikaki, PhD, studied psychology and neuroscience at the University of Crete in Greece. After obtaining her PhD, she pursued a post-doctoral research fellow position at The Scripps Research Institute in Scripps, Florida, where she utilized genetic mouse models to study mechanisms underlying motivation for food. She joined Dr. Chartoff’s laboratory at McLean Hospital as a post-...

Rachel A. Ross, MD, PhD

Rachel A. Ross, MD, PhD, is a psychiatric neuroscientist with an interest in anxiety disorders and feeding behavior in basic science, clinical treatment, and social policy. Dr. Ross’ background is in biological engineering, neuroscience, and the gut-brain axis, with clinical expertise is in psychiatry and metabolism. She is the assistant director for the Research Concentration Program for...

Dawn E. Sugarman, PhD

Dawn E. Sugarman, PhD, is a clinical psychologist in the Substance Use Disorders Division at McLean Hospital. Dr. Sugarman focuses her research and clinical work on the treatment of addictive behaviors. She is particularly interested in gender-specific treatment for substance use disorders and the use of technology in effective treatment dissemination. Previously, Dr. Sugarman’s research...